Walleye Capital Portfolio holdings
AUM
$10.8B
1-Year Return
8.39%
This Quarter Return
+7.36%
1 Year Return
+8.39%
3 Year Return
+34.69%
5 Year Return
+89.54%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$1.78B
(+20%)
Cap. Flow
-$379M
Cap. Flow
% of AUM
-3.51%
Top 10 Holdings %
Top 10 Hldgs %
23.09%
Holding
2,398
New
504
Increased
593
Reduced
637
Closed
458
Top Buys
| 1 |
Microsoft
MSFT
|
+$440M |
| 2 |
Palantir
PLTR
|
+$167M |
| 3 |
AT&T
T
|
+$67.9M |
| 4 |
AutoZone
AZO
|
+$65.8M |
| 5 |
Caterpillar
CAT
|
+$58.8M |
Top Sells
| 1 |
Apple
AAPL
|
+$136M |
| 2 |
NVIDIA
NVDA
|
+$114M |
| 3 |
Netflix
NFLX
|
+$89.2M |
| 4 |
Occidental Petroleum
OXY
|
+$66.5M |
| 5 |
Mercado Libre
MELI
|
+$63.5M |
Sector Composition
| 1 | Technology | 24.91% |
| 2 | Consumer Discretionary | 17.84% |
| 3 | Financials | 10.77% |
| 4 | Industrials | 10.07% |
| 5 | Healthcare | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Cullinan Oncology
CGEM
$391M
| $265K | ﹤0.01% |
35,199
+13,199
| +60% | +$99.4K |
|
1227
MicroSectors FANG+ ETNs due Jan 8 2038
FNGS
$520M
| $262K | ﹤0.01% |
4,022
-2,700
| -40% | -$176K |
|
1228
Amcor
AMCR
$19.2B
| $260K | ﹤0.01% |
+28,243
| New | +$260K |
|
1229
Alcoa
AA
$8.36B
| $259K | ﹤0.01% |
8,762
-21,338
| -71% | -$630K |
|
1230
Lyell Immunopharma
LYEL
$256M
| $258K | ﹤0.01% |
+29,230
| New | +$258K |
|
1231
Garrett Motion
GTX
$2.69B
| $257K | ﹤0.01% |
+24,500
| New | +$257K |
|
1232
Zimmer Biomet
ZBH
$20.7B
| $257K | ﹤0.01% |
2,822
-5,176
| -65% | -$472K |
|
1233
Nordson
NDSN
$12.8B
| $257K | ﹤0.01% |
+1,200
| New | +$257K |
|
1234
Allot
ALLT
$432M
| $257K | ﹤0.01% |
+30,000
| New | +$257K |
|
1235
Nutanix
NTNX
$21.7B
| $255K | ﹤0.01% |
3,341
-73,455
| -96% | -$5.61M |
|
1236
American Homes 4 Rent
AMH
$12.8B
| $255K | ﹤0.01% |
+7,074
| New | +$255K |
|
1237
Aflac
AFL
$58.1B
| $254K | ﹤0.01% |
2,409
+2,036
| +546% | +$215K |
|
|
GUG
1238
Guggenheim Active Allocation Fund
GUG
$536M
| $254K | ﹤0.01% |
16,220
-16,712
| -51% | -$261K |
|
1239
Broadridge
BR
$29.8B
| $252K | ﹤0.01% |
1,035
-7,586
| -88% | -$1.84M |
|
1240
Labcorp
LH
$23.2B
| $250K | ﹤0.01% |
952
-31,038
| -97% | -$8.15M |
|
1241
Peoples Bancorp
PEBO
$1.09B
| $249K | ﹤0.01% |
+8,163
| New | +$249K |
|
1242
Unitil
UTL
$832M
| $245K | ﹤0.01% |
+4,702
| New | +$245K |
|
1243
Toast
TOST
$23.8B
| $243K | ﹤0.01% |
5,482
-7,435
| -58% | -$329K |
|
1244
Vital Energy
VTLE
$649M
| $242K | ﹤0.01% |
15,039
-22,821
| -60% | -$367K |
|
1245
Selective Insurance
SIGI
$4.85B
| $242K | ﹤0.01% |
+2,788
| New | +$242K |
|
1246
Myriad Genetics
MYGN
$715M
| $241K | ﹤0.01% |
45,472
-141,130
| -76% | -$749K |
|
1247
Commault Systems
CVLT
$8.04B
| $240K | ﹤0.01% |
1,376
+21
| +2% | +$3.66K |
|
1248
Radian Group
RDN
$4.81B
| $239K | ﹤0.01% |
+6,623
| New | +$239K |
|
1249
Axsome Therapeutics
AXSM
$6.14B
| $238K | ﹤0.01% |
2,283
+697
| +44% | +$72.8K |
|
|
SMTK
1250
SmartKem
SMTK
$7.86M
| $238K | ﹤0.01% |
240,082
+142,898
| +147% | +$141K |
|